Post by
Janemorris55 on Sep 23, 2021 12:09pm
FSD to pursue strategic acquisitions
FSD Pharma is well-capitalized with a cash of $43.2 million, as of June 30, 2021, to pursue strategic acquisitions. The most recent one is Lucid. This move opens markets and opportunities for the company.
Comment by
DavidRosenberg on Sep 23, 2021 1:19pm
Like i said AD has alot of skin in the company , he would equally want to see it be a success same like us retail investors in my opinion. Time will tell if they are able to achieve this I think this time with UHN and Lucid Real smart brains are implementing moves to help grow the company